Addressing the Interplay of Liver Disease and Hepatocellular Carcinoma on Patient Survival: The ALBI Scoring Model
- 20 February 2015
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 33 (6) , 529-531
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI GradeJournal of Clinical Oncology, 2015
- Current Strategy for Staging and Treatment: The BCLC Update and Future ProspectsSeminars in Liver Disease, 2010
- Validation of a New Prognostic Staging System for Hepatocellular Carcinoma: A Comparison of the Biomarker-Combined Japan Integrated Staging Score, the Conventional Japan Integrated Staging Score and the BALAD ScoreOncology, 2008
- Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP, TNM and CUPIJournal of Gastroenterology and Hepatology, 2008
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Prognosis of hepatocellular carcinomaHepatology, 2005
- Validation of A New Prognostic Staging System for Hepatocellular Carcinoma: the Jis Score Compared With the Clip ScoreHepatology, 2004
- Hepatocellular carcinomaThe Lancet, 2003
- Prognosis of Hepatocellular Carcinoma: The BCLC Staging ClassificationSeminars in Liver Disease, 1999
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973